Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand.
Norway’s market for non-prescription medicines remained roughly stable in 2018, according to figures from local pharmaceutical industry association Legemiddelindustrien (LMI) and Farmastat.
Sales of non-prescription products over the 12 months edged up by 0.3% to NOK1.45bn ($170m) at pharmacy purchase prices
Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
